Multigram synthesis and in vivo efficacy studies of a novel multitarget anti-Alzheimer's compound

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Irene SolaDiego Muñoz-Torrero

Abstract

We describe the multigram synthesis and in vivo efficacy studies of a donepezil‒huprine hybrid that has been found to display a promising in vitro multitarget profile of interest for the treatment of Alzheimer's disease (AD). Its synthesis features as the key step a novel multigram preparative chromatographic resolution of intermediate racemic huprine Y by chiral HPLC. Administration of this compound to transgenic CL4176 and CL2006 Caenorhabditis elegans strains expressing human Aβ42, here used as simplified animal models of AD, led to a significant protection from the toxicity induced by Aβ42. However, this protective effect was not accompanied, in CL2006 worms, by a reduction of amyloid deposits. Oral administration for 3 months to transgenic APPSL mice, a well-established animal model of AD, improved short-term memory, but did not alter brain levels of Aβ peptides nor cortical and hippocampal amyloid plaque load. Despite the clear protective and cognitive effects of AVCRI104P4, the lack of Aβ lowering effect in vivo might be related to its lower in vitro potency toward Aβ aggregation and formation as compared with its higher anticholinesterase activities. Further lead optimization in this series should thus focus on improvin...Continue Reading

References

Aug 19, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S D StyrenW E Klunk
Apr 2, 2003·European Journal of Medicinal Chemistry·Li DiGuy T Carter
Apr 7, 2005·Genes, Brain, and Behavior·C D Link
Oct 14, 2005·Journal of Medicinal Chemistry·Richard Morphy, Zoran Rankovic
Nov 16, 2006·Current Pharmaceutical Design·Ana Castro, Ana Martinez
Dec 15, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yanjue WuYuan Luo
Jan 10, 2008·Journal of Medicinal Chemistry·Andrea CavalliCarlo Melchiorre
Jul 29, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Pilar Franco, Tong Zhang
Oct 16, 2008·Current Medicinal Chemistry·D Muñoz-Torrero
Jan 7, 2009·The International Journal of Biochemistry & Cell Biology·Sanjay W Pimplikar
May 1, 2010·Nature Reviews. Drug Discovery·Martin Citron
Mar 16, 2011·Journal of Alzheimer's Disease : JAD·Daniel HavasManfred Windisch
Feb 16, 2013·Current Medicinal Chemistry·W J Geldenhuys, C J Van der Schyf
Feb 16, 2013·Current Medicinal Chemistry·P RussoA Cesario
Apr 25, 2013·Journal of Medicinal Chemistry·Tatiana StoilovaMario Salmona
Jun 8, 2013·Current Opinion in Pharmacology·Marten BeegMarco Gobbi
Oct 8, 2013·Experimental Neurology·Jia Li, Weidong Le
May 6, 2014·Methods : a Companion to Methods in Enzymology·Yuli VolovikEhud Cohen
Dec 3, 2014·Neurobiology of Aging·Wail M HassanChristopher D Link

❮ Previous
Next ❯

Citations

Sep 6, 2018·International Journal of Molecular Sciences·Julia RelatM Victòria Clos
Feb 20, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fangzhou DuXueqi Fu
Oct 10, 2020·Neuropharmacology·Gabriella MarucciFrancesco Amenta

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
column chromatography
dot blot
dot

Software Mentioned

GraphPad
Progenesis SameSpots
AxioVision
Image Pro Plus

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.